Ohr Pharmaceuticals Revenue, Profits - OHRP Quarterly Income Statement

Add to My Stocks
$0.18 $0.01 (5.26%) OHRP stock closing price Sep 19, 2018 (Closing)

Financial analysis of Ohr Pharmaceuticals involves more than just checking the Ohr Pharmaceuticals stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q3 impacts the OHRP stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Ohr Pharmaceuticals assets and Ohr Pharmaceuticals free cash flow, Ohr Pharmaceuticals profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q3 is $-0.55M and the 2018 Q3 revenue is $-.

View and download details of revenue and profits for Ohr Pharmaceuticals for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Ohr Pharmaceuticals Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
Ohr Pharmaceuticals Gross Profit
----------
Research & Development Expense-1.8M2.38M4.25M2.23M5.99M4.93M4.72M5.63M4.04M
Selling General & Admin Expense--1.51M-1.33M1.4M1.74M1.82M1.66M2.25M
Income Before Depreciation Depletion Amortization-0.89M-1.9M-3.89M-4.99M-3.56M-7.39M-6.67M-6.52M-7.3M-6.29M
Depreciation Depletion Amortization----------
Non Operating Income-----0.04M----0.1M1.31M
Interest Expense--------0.01M--
Ohr Pharmaceuticals Pretax Income
-0.55M-2.18M-4.15M-5.25M-3.9M-7.69M-6.97M-6.65M-7.69M-5.28M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-0.55M-2.19M-4.2M-5.23M-3.9M-7.7M-6.98M-6.64M-7.7M-5.29M
Extraordinary Items & Discontinued Operations----------
Ohr Pharmaceuticals Profit/ Loss (Net Income)
-0.55M-2.19M-4.2M-5.23M-3.9M-7.7M-6.98M-6.64M-7.7M-5.29M
Average Shares used to compute Diluted EPS50M56.47M60M65.43M53.99M36.67M32.84M31.35M31.5M31.34M
Average Shares used to compute Basic EPS50M56.47M60M65.43M53.99M36.67M32.84M31.35M31.5M31.34M
Income Before Nonrecurring Items-0.5M-2.67M-4.2M-5.23M-3.9M-7.7M-6.98M-6.64M-7.7M-5.29M
Income from Nonrecurring Items----------
Ohr Pharmaceuticals Earnings Per Share Basic Net
-0.01-0.04-0.07-0.08-0.07-0.21-0.21-0.21-0.24-0.17
Ohr Pharmaceuticals Earnings Per Share Diluted Net
-0.01-0.04-0.07-0.08-0.07-0.21-0.21-0.21-0.24-0.17
EPS Diluted Before Nonrecurring Items-0.01-0.05-0.07-0.08-0.07-0.21-0.21-0.21-0.24-0.17
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Pfizer financial analysis

The key things to look for in an income statement while doing Ohr Pharmaceuticals stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2018 Q3. Our Ohr Pharmaceuticals revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. OHRP stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The OHRP financials along with Ohr Pharmaceuticals historical stock prices provide a lot of details about the firm.

Ohr Pharmaceuticals Income Statement - Key Financial Ratios